Philips SmartIQ aims to cut coronary imaging radiation dose
The coronary imaging technology adds an ultra-low-dose protocol for Philips’ Azurion image-guided therapy platform and is available in Europe and selected markets.
Philips has introduced SmartIQ, a coronary imaging technology for its Azurion image-guided therapy platform. The technology is designed to improve coronary image quality while reducing radiation exposure for patients and clinical staff, according to the company.
SmartIQ includes an ultra-low-dose protocol for coronary procedures. Philips said the protocol uses more than 50% less X-ray radiation dose than the lowest dose settings available with its ClarityIQ platform.
A first blinded clinical pilot study was published in the Journal of the Society for Cardiovascular Angiography & Interventions. Philips said the algorithm scored higher on image quality and was preferred in most blinded comparisons while maintaining or lowering radiation and contrast dose.
ClarityIQ has previously been associated with radiation exposure reductions between 23% and 83%, depending on the clinical area, according to Philips. SmartIQ builds on that platform for coronary imaging.
RADIQAL, an ongoing trial, is assessing SmartIQ’s effect on radiation dose compared with ClarityIQ while maintaining procedural performance. Philips said the study has reached 60% of total enrollment and completed enrollment at European sites.
At EuroPCR 2026 in Paris, Philips will show SmartIQ alongside other image-guided therapy technologies, including IntraSight Plus, DeviceGuide, VeriSight Pro 3D ICE, and Hemo R2.
SmartIQ has received CE mark and is available in Europe and selected markets on new and existing Azurion systems. Philips said the technology has not yet received U.S. FDA clearance.
Company:Philips
About the author
RadiologySignal.com writersEditorial Team
Radiology Signal Staff covers developments across medical imaging, radiology AI, imaging informatics, clinical research, and radiology business. The team monitors primary sources, peer-reviewed studies, company announcements, society updates, and healthcare industry news to deliver concise reporting for imaging professionals.
More from this section
SimonMed highlights role in large global X-ray AI study
The study analyzed 258,373 X-rays from 100 medical centers across 26 countries and evaluated the Rayvolve AI Suite across trauma, chest, measurement, and bone age use cases.
Neurophet names Lawrence Tanenbaum scientific advisor
The neuroradiologist and former RadNet CTO will advise the neuroimaging AI company as it seeks to strengthen clinical validation and U.S. market expansion.
CMR-CLIP AI model interprets cardiac MRI scans with high accuracy
The model was trained on more than 13,000 cardiac MRI studies and linked moving heart images with clinical radiology reports, according to the research team.
Flywheel integrates with AWS HealthImaging
The integration combines AWS HealthImaging’s cloud-based DICOM storage with Flywheel’s imaging data orchestration tools for clinical trials, research, and AI development.
GE HealthCare opens free HelloAI training program
The company is making the HelloAI Professional track available at no cost, adding more than 20 hours of on-demand healthcare AI education.
Siemens links coronary CT planning to cath-lab PCI guidance
The system combines Syngo.CT Coronary Cockpit and Syngo PCI Connect to transfer preprocessed coronary CT angiography data into the cath lab.
AZmed gets FDA clearance for expanded AZtrauma scope
The clearance expands AZtrauma beyond fracture detection to include joint effusions and dislocations on X-rays in adults and children ages 2 years and older.
HOPPR launches mammography vision-language model
The HOPPR EB 2D Mammo Narrative Model generates structured narrative output from 2D mammography images for breast imaging workflow applications.
DeepHealth secures AI clearances for neuro, prostate tools
The regulatory milestones cover Neuro Suite Brain Health and Brain Age, LumbarMR, and Prostate AI within DeepHealth’s clinical AI portfolio.
Philips introduces SmartIQ for Azurion coronary imaging
The coronary imaging technology adds an ultra-low-dose protocol for Philips’ Azurion image-guided therapy platform and is available in Europe and selected markets.
Azra AI, RevealDx partner on lung nodule AI
Azra AI will integrate RevealAI-Lung into its incidental findings and oncology workflow platform.
Accuro XV clearance gives Rivanna path into MSK ultrasound
Rivanna received FDA 510(k) clearance for Accuro XV, a diagnostic ultrasound system for musculoskeletal imaging. The company is also developing AI tools for bone visualization and fracture detection.